Scientific paper - Original scientific paper
Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes
New England Journal of Medicine, 377 (2017), 8; 723-732. https://doi.org/10.1056/NEJMoa1615692

Marso, Stiven P.; McGuire, Darren K.; Zinman, Bernard; Poulter, Neil R.; Emerson, Scott S.; Pieber, Thomas R.; Pratley, Richard E.; Haahr, Poul-Martin; Lange, Martin; Brown-Frandsen, Kirstine; Moses, Alan; Skibsted, Simone; Kvist, Kajsa; Buse, John B.

Cite this document

Marso, S. P., McGuire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pieber, T. R. ... Buse, J. B. (2017). Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes. New England Journal of Medicine, 377. (8), 723-732. doi: 10.1056/NEJMoa1615692

Marso, Stiven P., et al. "Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes." New England Journal of Medicine, vol. 377, no. 8, 2017, pp. 723-732. https://doi.org/10.1056/NEJMoa1615692

Marso, Stiven P., Darren K. McGuire, Bernard Zinman, Neil R. Poulter, Scott S. Emerson, Thomas R. Pieber, Richard E. Pratley, et al. "Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes." New England Journal of Medicine 377, no. 8 (2017): 723-732. https://doi.org/10.1056/NEJMoa1615692

Marso, S. P., et al. (2017) 'Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes', New England Journal of Medicine, 377(8), pp. 723-732. doi: 10.1056/NEJMoa1615692

Marso SP, McGuire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR, and sur.. Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes. New England Journal of Medicine [Internet]. 2017 [cited 2022 October 07];377(8):723-732. doi: 10.1056/NEJMoa1615692

S. P. Marso, et al., "Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes", New England Journal of Medicine, vol. 377, no. 8, pp. 723-732, 2017. [Online]. Available at: https://urn.nsk.hr/urn:nbn:hr:239:882161. [Accessed: 07 October 2022]

Please login to the repository to save this object to your list.